Search - tctmd.com

Displaying 761 - 780 of 922

Sort: Relevancy | Date

News Daily News

Patients Less Likely to Take Secondary Prevention Medications After CABG Than PCI

December 12, 2012

News Daily News

Los Pacientes son Menos Propensos a Tomar Fármacos de Prevención Secundarios tras una CABG que tras una PCI

December 12, 2012

News Daily News

Extended Dual Antiplatelet Therapy Lowers Death, MI Rates in DES Patients

Jason Kahn

December 05, 2012

News Daily News

Un Modelo Confirma la Rentabilidad de la Denervación Renal en Varones y Mujeres

L.A. McKeown

December 02, 2012

News Daily News

Model Shows Cost-Effectiveness of Renal Denervation in Men, Women

L.A. McKeown

December 02, 2012

News Daily News

Nuevas directrices asumen un enfoque integral con respecto a la enfermedad cardíaca isquémica estable

Kim Dalton

November 19, 2012

News Daily News

New Guidelines Take Integrated Approach to Stable Ischemic Heart Disease

Kim Dalton

November 19, 2012

Presentation TCT 2012

Part 2: Only a Research Tool

Presenter: Ajay Kirtane

October 25, 2012

Presentation TCT 2012

Frequency, Prevention, and Management of DES Thrombosis

Presenter: Ajay Kirtane

October 25, 2012

Presentation TCT 2012

Case Presentation 2: Example of Abuse of AUC

Presenter: Ajay Kirtane

October 24, 2012

Presentation TCT 2012

PCI and CABG from Bari to Syntax: Incorporating the Data Into Practice

Presenter: Ajay Kirtane

October 23, 2012

Presentation TCT 2012

Late Breaking Clinical Trials: BRIDGE-ACS (Multimodality Approach to Adherence), INFUSE-AMI (STEMI), and IMMEDIATE (GIK)

Presenter: Ajay Kirtane

October 23, 2012

Presentation TCT 2012

Bare Metal vs. Drug-Eluting Stents: Mechanisms of Action and Comparative Effectiveness and Safety

Presenter: Ajay Kirtane

October 23, 2012

Presentation TCT 2012

Introduction(4)

Presenter: Ajay Kirtane

October 23, 2012

Presentation TCT 2012

The Influence of Gender on Clinical Outcomes in the PARTNER Trial

Presenter: Ajay Kirtane

October 22, 2012

Presentation TCT 2012

Position 4. Patient Preference Matters: Use PCI with DES Early and Liberally in Most Patients!

Presenter: Ajay Kirtane

October 22, 2012

News Conference News TCT 2012

PARTNER Analyses Provide Important Insights into TAVR

October 22, 2012

Presentation TCT 2012

Meta-Analyses: Strengths and Weaknesses

Presenter: Ajay Kirtane

October 22, 2012

Presentation TCT 2012

Coronary Angiography II: Artifacts and Pitfalls

Presenter: Ajay Kirtane

October 21, 2012

News Daily News

La Estrategia Precoz Agresiva en Pacientes Ancianos con SCASEST No es Perjudicial aunque la Ventaja sigue siendo Elusiva

Caitlin E. Cox

September 20, 2012

Advertisement

Patients Less Likely to Take Secondary Prevention Medications After CABG Than PCI

Los Pacientes son Menos Propensos a Tomar Fármacos de Prevención Secundarios tras una CABG que tras una PCI

Extended Dual Antiplatelet Therapy Lowers Death, MI Rates in DES Patients

Un Modelo Confirma la Rentabilidad de la Denervación Renal en Varones y Mujeres

Model Shows Cost-Effectiveness of Renal Denervation in Men, Women

Nuevas directrices asumen un enfoque integral con respecto a la enfermedad cardíaca isquémica estable

New Guidelines Take Integrated Approach to Stable Ischemic Heart Disease

Part 2: Only a Research Tool

Frequency, Prevention, and Management of DES Thrombosis

Case Presentation 2: Example of Abuse of AUC

PCI and CABG from Bari to Syntax: Incorporating the Data Into Practice

Late Breaking Clinical Trials: BRIDGE-ACS (Multimodality Approach to Adherence), INFUSE-AMI (STEMI), and IMMEDIATE (GIK)

Bare Metal vs. Drug-Eluting Stents: Mechanisms of Action and Comparative Effectiveness and Safety

Introduction(4)

The Influence of Gender on Clinical Outcomes in the PARTNER Trial

Position 4. Patient Preference Matters: Use PCI with DES Early and Liberally in Most Patients!

PARTNER Analyses Provide Important Insights into TAVR

Meta-Analyses: Strengths and Weaknesses

Coronary Angiography II: Artifacts and Pitfalls

La Estrategia Precoz Agresiva en Pacientes Ancianos con SCASEST No es Perjudicial aunque la Ventaja sigue siendo Elusiva

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content